Preclinical Validation of an Epigenetic Modifier Gene Therapy for the Treatment of Dry AMD

Time: 1:15 am

Details:

  • Introduction of a therapy with a novel mechanism of action for dry AMD
  • Efficacy data in multiple rodent models of dry AMD
  • Presentation of a novel animal model of dry AMD with spaceflight to low earth orbit

Speakers: